Effect of carrot intake on cholesterol metabolism and on antioxidant status in cholesterol-fed rat

被引:80
作者
Nicolle, C
Cardinault, N
Aprikian, O
Busserolles, J
Grolier, P
Rock, E
Demigné, C
Mazur, A
Scalbert, A
Amouroux, P
Rémésy, C
机构
[1] Vilmorin Clause & Cie, F-63720 Chappes, France
[2] INRA, Unite Malad Metab & Micronutriments, F-63122 St Genes Champanelle, France
关键词
carrot; carotenoids; antioxidants; lipemia; BETA-CAROTENE; LIPID-PEROXIDATION; OXIDATIVE MODIFICATION; FATTY-ACIDS; BILE-ACIDS; PLASMA; VEGETABLES; LIPOPROTEIN; VITAMINS; SERUM;
D O I
10.1007/s00394-003-0419-1
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Background Vegetables are major dietary sources of fibers and antioxidants such as carotenoids, polyphenols and vitamin C which contribute to explain their protective effects against cardiovascular diseases. Aim of the study We investigated in the rat the effects of a 3-week supplementation of the diet with carrot (15 dry matter) on lipid metabolism and antioxidant status. Results A significant decrease of cholesterol level in liver (-44 %; P = 0.0007) was observed together with a reduction of the level of liver triglycerides (-40 %; P= 0.0005). Fecal total steroids excretion increased by 30 % upon feeding the carrot diet as compared to the control. The secretion of bile acids was maintained, whereas the cholesterol apparent absorption was reduced in rats fed carrot diet. Carrot consumption also improved the antioxidant status. It significantly decreased the urinary excretion of thiobarbituric acid reactive substances (TBARS), reduced the TBARS levels in heart, increased the vitamin E plasmatic level and tended to increase the ferric reducing ability of plasma (FRAP) as compared to the controls. The carrot diet provided carotenoid antioxidants: 5.1 mg beta-carotene, 1.6 mg alpha-carotene and 0.25 mg lutein per 100 g diet. No carotenoids were found in plasma whereas the three carotenoids were detected in the plasma of the rats fed the carrot diet at 125, 41, 43 nmol/L respective concentrations. beta-Carotene was also detected in liver and heart. Conclusion Carrot consumption modifies cholesterol absorption and bile acids excretion and increases antioxidant status and these effects could be interesting for cardiovascular protection.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 47 条
[1]
Comparison of volatiles, phenolics, sugars, antioxidant vitamins, and sensory quality of different colored carrot varieties [J].
Alasalvar, C ;
Grigor, JM ;
Zhang, DL ;
Quantick, PC ;
Shahidi, F .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (03) :1410-1416
[2]
[Anonymous], 1995, FOOD PHENOLICS SOURC
[3]
Apple favourably affects parameters of cholesterol metabolism and of anti-oxidative protection in cholesterol-fed rats [J].
Aprikian, O ;
Levrat-Verny, MA ;
Besson, C ;
Busserolles, J ;
Rémésy, C ;
Demigné, C .
FOOD CHEMISTRY, 2001, 75 (04) :445-452
[4]
AUBERT S, 1981, CAH NUTR DIET, V16, P173
[5]
The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[6]
FRUIT, VEGETABLES, AND CANCER PREVENTION - A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE [J].
BLOCK, G ;
PATTERSON, B ;
SUBAR, A .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1992, 18 (01) :1-29
[7]
Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans [J].
Broekmans, WMR ;
Klöpping-Ketelaars, IAA ;
Schuurman, CRWC ;
Verhagen, H ;
van den Berg, H ;
Kok, FJ ;
van Poppel, G .
JOURNAL OF NUTRITION, 2000, 130 (06) :1578-1583
[8]
Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men [J].
Bub, A ;
Watzl, B ;
Abrahamse, L ;
Delincée, H ;
Adam, S ;
Wever, J ;
Müller, H ;
Rechkemmer, G .
JOURNAL OF NUTRITION, 2000, 130 (09) :2200-2206
[9]
Carr AC, 1999, AM J CLIN NUTR, V69, P1086
[10]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497